We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
901
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $24.9M | 0.01% |
202,947
-19,984
| -9% | -$2.27M |
|
902
Diodes
DIOD
$4.84B
| $24.9M | 0.01% |
490,943
-93,503
| -16% | -$4.47M |
|
903
Watsco Inc
WSO
$13.6B
| $24.9M | 0.01% |
139,990
-187,812
| -57% | -$31.1M |
|
|
AQUA
904
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $24.8M | 0.01% |
1,335,968
-155,149
| -10% | -$2.57M |
|
905
Herbalife
HLF
$1.29B
| $24.8M | 0.01% |
551,282
+72,864
| +15% | +$2.83M |
|
906
Eastman Chemical
EMN
$8.42B
| $24.7M | 0.01% |
355,153
-2,790
| -0.8% | -$176K |
|
907
Four Corners Property Trust
FCPT
$2.75B
| $24.7M | 0.01% |
1,012,937
+568,343
| +128% | +$12.2M |
|
908
Zions Bancorporation
ZION
$10.3B
| $24.7M | 0.01% |
726,448
+73,683
| +11% | +$2.33M |
|
909
WSFS Financial
WSFS
$4.15B
| $24.7M | 0.01% |
860,489
-9,334
| -1% | -$247K |
|
|
SEM
910
DELISTED
Select Medical
SEM
| $24.6M | 0.01% |
3,105,188
+110,044
| +4% | +$912K |
|
911
ON Semiconductor
ON
$31.6B
| $24.6M | 0.01% |
1,242,585
-16,338
| -1% | -$266K |
|
912
Bio-Rad Laboratories Class A
BIO
$9.42B
| $24.6M | 0.01% |
54,458
-10,282
| -16% | -$4.54M |
|
913
Boise Cascade
BCC
$3.02B
| $24.6M | 0.01% |
653,026
-19,837
| -3% | -$622K |
|
914
World Kinect Corp
WKC
$1.86B
| $24.5M | 0.01% |
951,448
+214,995
| +29% | +$5.29M |
|
915
CONMED
CNMD
$1.47B
| $24.5M | 0.01% |
340,130
+33,775
| +11% | +$2.35M |
|
916
Rollins
ROL
$18.2B
| $24.4M | 0.01% |
862,674
+4,530
| +0.5% | +$121K |
|
917
CareTrust REIT
CTRE
$9.74B
| $24.4M | 0.01% |
1,419,993
+675,805
| +91% | +$11.8M |
|
918
Glacier Bancorp
GBCI
$6.35B
| $24.3M | 0.01% |
689,799
+326,196
| +90% | +$12.1M |
|
|
CZR
919
DELISTED
Caesars Entertainment Corporation
CZR
| $24.3M | 0.01% |
2,000,831
-20,427
| -1% | -$206K |
|
|
VISN
920
Vistance Networks Inc
VISN
$2.52B
| $24.3M | 0.01% |
2,911,897
+682,092
| +31% | +$6.74M |
|
921
Bio-Techne
TECH
$11.3B
| $24.2M | 0.01% |
366,548
+14,884
| +4% | +$891K |
|
922
Workiva
WK
$3.54B
| $24.2M | 0.01% |
452,135
+49,701
| +12% | +$2.04M |
|
|
TERP
923
DELISTED
TerraForm Power, Inc
TERP
| $24.1M | 0.01% |
1,307,313
-429,847
| -25% | -$7.61M |
|
924
BWX Technologies
BWXT
$15.6B
| $24.1M | 0.01% |
425,368
-107,799
| -20% | -$6.03M |
|
925
RPM International
RPM
$15B
| $24M | 0.01% |
319,769
-3,539
| -1% | -$246K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.